Back to ITN Home

Overview and Mission
News and Press


Research Supported
ITN Protocols
Meeting calendar
Related Links
Employment opportunities at the ITN
Clinical Trials Seeking Patients

Contact Information

Links and Resources
| Public Access Site for Researchers | Click to change to non-technical version |

Scientific Societies & Organizations

GENERAL

· FOCIS - Federation of Clinical Immunology Societies www.focisnet.org

· American Society for Histocompatibility and Immunogenetics - www.ashi-hla.org

· American Association of Immunologists www.aai.org

· Clinical Immunology Association - www.clinimmsoc.org  

IMMUNE TOLERANCE ON THE WEB

· Indices of Tolerance www.transplant-tolerance.org.uk

· Conceptual Immune Tolerance Group@ Harvard
  www.chip.org/~asher/citg/

TRANSPLANTATION

· American Society of Transplant Surgeons www.asts.org

· American Society of Transplantation www.a-s-t.org

· International Liver Transplantation Society www.ilts.org

· International Pancreas and Islet Transplant Association www.ipita.org

· American Association for the Study of Liver Diseases www.aasld.org

AUTOIMMUNE DISEASES

· Immunology of Diabetes Society www.idsoc.org

· Type 1 Diabetes TrialNet www.diabetestrialnet.org

ALLERGY & ASTHMA

· American Academy of Allergy, Asthma and Immunology www.aaaai.org

Industry Links

Biogen - a global biotechnology company discovering and developing drugs, many targeting diseases of the immune system. [open]

Biotransplant - is developing therapeutics and systems to re-educate the body's immune system to accept transplanted cells, tissues and organs [open]

Bristol Myers Squibb - developing a number of tolerogenic agents in transplantation and rheumatoid arthritis. [open]

Corixa - developing new vaccines for the treatment of rheumatoid arthritis and multiple sclerosis [open]

IDEC Pharmaceuticals - pharmaceutical firm developing new drugs for autoimmune and inflammatory diseases, including an anti-CD40 ligand for costimulatory blockade [open]

La Jolla Pharmaceutical Company - a biotechnology company developing therapeutics for antibody-mediated autoimmune diseases, with phase III trials in lupus kidney disease. [open]

Medimmune - Developing an anti-CD2 monoclonal antibody for psoriasis [open]

Millennium Pharmaceuticals - biopharmaceutical company involved int eh development of new agents, including Campath. [open]

Repligen - biotechnology company focused on developing new drugs for, among other things, immune and metabolic disorders [open]


Research Funding

· National Institute of Allergy & Infectious Disease www.niaid.nih.gov

· National Institute of Diabetes and Digestive and Kidney Diseases www.niddk.nih.gov

· Juvenile Diabetes Research Foundation www.jdrf.org

· Roche Organ Transplantation Research Foundation www.rotrf.org



HomeTerms | © 2002-5 Immune Tolerance Network | Sponsors: NIAID, NIDDK and JDRF | Search